New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).

COVID-19 infection: an overview on cytokine storm and related interventions, Virology Journal

New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week

Full article: Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research

Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis - ScienceDirect

COVID-19 therapeutics: Challenges and directions for the future

The current landscape of long COVID clinical trials: NIH's RECOVER to Stanford Medicine's STOP-PASC initiative: Molecular Therapy - Nucleic Acids

The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID

Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape - Haley Hedlin, Ariadna Garcia, Yingjie Weng, Ziyuan He, Vandana Sundaram, Bryan Bunning, Vidhya Balasubramanian, Kristen

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID- 19: JACC State-of-the-Art Review - ScienceDirect

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico